Southern Clinical Development Consulting
Southern Clinical Development Consulting is a Melbourne-based, privately held clinical development consultancy providing vendor oversight, trial management, and strategic consultancy services to pharmaceutical, biotech, and academic clients across pre-clinical through Phase 1 programs.
- Company typePrivate
- Founded2023
- HeadquartersMelbourne, Australia
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Southern Clinical Development Consulting does
Southern Clinical Development Consulting (Southern CDC) is a privately held clinical development consultancy headquartered in Melbourne, Australia. The firm provides clinical trial consultancy, vendor oversight and management, and strategic ad-hoc services to pharmaceutical companies, biotechnology firms, academic institutions, and clinical investigators. Its core focus is supporting assets from pre-clinical through Phase 1 (First-In-Human) clinical trials, covering protocol and investigator brochure development, risk assessments, recruitment strategies, site feasibility and management, safety reporting, regulatory affairs, CMC support, and quality control/auditing.
The company's service portfolio is organized into three delivery models: Strategic Ad-hoc Consultancy with Vendor Oversight, In-House Services, and a Hybrid Model leveraging a vetted vendor network. These are priced via bespoke project or retainer arrangements, with master consultancy agreements enabling client onboarding within two weeks. Southern CDC differentiates through a "sponsor control framework" intended to give clients direct oversight of their trials rather than relying on a full-service CRO, supported by a flat organizational structure and modular teams designed to reduce cost without change orders.
Commercially, the company operates as a sales-led professional services firm relying on direct engagement, industry relationships, and a corporate website (southerncdc.com) for lead generation. The leadership team, including CEO Dr Ardian Latifi and COO Dr Khalid Abubaker, brings 20+ years of pharmaceutical and biotech experience from organizations such as Bristol Myers Squibb, Merck, IQVIA, and Syneos Health. The firm is founder-managed, has no disclosed external investors, no disclosed revenue, and no disclosed partnerships or acquisitions.
Southern Clinical Development Consulting firmographics
Firmographics- Name
- Southern Clinical Development Consulting
- Legal name
- Southern Clinical Development Consulting
- Website
- https://southerncdc.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Southern Clinical Development Consulting is a Melbourne-based, privately held clinical development consultancy providing vendor oversight, trial management, and strategic consultancy services to pharmaceutical, biotech, and academic clients across pre-clinical through Phase 1 programs.
- Ownership category
- akta.pro rank
Southern Clinical Development Consulting industry classification
Industry- Product category
- Clinical Development Consulting Services
- NAICS
- Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Management Consulting Services (8742), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industries
- Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE), Nonclinical Study Management & Regulatory Writing (IND-enabling) (HLAGAFAN), Clinical Trial Financial Management & Payments (Site Budgeting) (HLAGACAM)
Keywords
Where Southern Clinical Development Consulting is headquartered
LocationHeadquarters
- HQ city
- Melbourne
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Southern Clinical Development Consulting business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Clinical Development Consultancy Services: The company generates revenue through professional services engagements providing clinical trial consultancy, vendor oversight/management, and strategic ad-hoc services to sponsors. Services include local sponsor representative, protocol and IB development, risk assessments, recruitment strategies, site management, safety reporting, and quality control/auditing. Revenue appears to be project-based or retainer arrangements for ongoing vendor management.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Southern Clinical Development Consulting product offering
Product offeringCore offering
Southern Clinical Development Consulting is a clinical development consultancy that delivers vendor oversight and management, in-house clinical trial services, and a hybrid model leveraging vetted third-party vendors for pharmaceutical and biotech sponsors. Services span the full pre-clinical through Phase 1 (First-In-Human) pathway and include local sponsor representation, protocol and investigator brochure development, risk assessments, recruitment strategies, site startup and feasibility, site management, safety reporting, budgets and contracts, regulatory and CMC advisory, and ongoing quality control and auditing. Engagements are delivered under bespoke consultancy agreements or a master consultancy agreement that enables sponsor access to all services within two weeks.
Product overview
Southern Clinical Development Consulting is a clinical development service provider offering a portfolio of interconnected consultancy and clinical trial management services organized into three main service lines: Strategic Ad-hoc Consultancy Services with Vendor Oversight/Management, In-House Services, and a Hybrid Model by Partnering with Others. These services are complemented by four solution components focused on Faster Timelines, Competitive Costs, Quality Data, and Tailored Management Services. The company primarily focuses on enabling assets from pre-clinical studies into Phase 1 (First-In-Human) clinical trials.
Differentiator
Problem solved
Functional benefit
Products and services
- Strategic Ad-hoc Consultancy Services and Vendor Oversight/Management Consultancy services providing vendor oversight and management for pharmaceutical and biotech sponsors, including pre-clinical data/tox advice, CMC regulatory services, clinical operations, and ongoing clinical trial support and oversight.
- In-House Services Comprehensive in-house clinical trial services including local sponsor representative, protocol and investigator brochure development, risk assessments, recruitment strategies, site startup activities, site feasibility and management, safety reporting, and budgets and contracts.
- Hybrid Model by Partnering with Others Managed vendor services utilizing a vetted network of third-party vendors, including ongoing vendor management, outreach to new vendors, feasibility and vendor selection on behalf of sponsors, and quality control and auditing.
Quantifiable outcome
- Sponsors can access all services within the organisation in less than 2 weeks through master consultancy agreement
Companies that use Southern Clinical Development Consulting
Customer profileSegments3 records
Ideal customer profiles3 records
Southern Clinical Development Consulting technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Southern Clinical Development Consulting partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights3 records
Southern Clinical Development Consulting competitors and assessment
Company assessmentBroad incumbents
- Syneos Health: Large global biopharmaceutical solutions organization offering clinical development and commercialization services. Southern CDC's BD Director previously won the GM Star Employee Award at Syneos; represents the broad incumbent whose service breadth Southern CDC substitutes with senior-led boutique delivery.
- Worldwide Clinical Trials: Mid-to-large global CRO offering full-service clinical development across multiple therapeutic areas. Comparable at the industry level to Southern CDC, with overlapping therapeutic areas (oncology, cardiology, rare disease) but materially larger scale.
- IQVIA: Largest global CRO and life sciences services provider offering the full clinical development spectrum. Southern CDC leadership includes former IQVIA staff; IQVIA represents the scale incumbent whose rigid full-service model Southern CDC's sponsor-centric framework is designed to disrupt.
- Parexel: Major global CRO providing full-service clinical development and regulatory consulting across all phases. Comparable to Southern CDC at the broader industry level, but at vastly larger scale and with full Phase 1-4 capabilities.
Direct peers
- Biorasi: Boutique CRO focused on small to mid-sized biotech and pharma sponsors with flexible, sponsor-friendly engagement models. Highly comparable in business model philosophy (modular, sponsor-centric) and target customer segment to Southern CDC.
- Cromos Pharma: Boutique CRO serving biotech and pharma sponsors with full-service clinical trial capabilities and a flexible engagement model. Comparable to Southern CDC in target customer base and emphasis on boutique, sponsor-friendly delivery.
- Medpace: Mid-size CRO focused on small to mid-sized biotech and pharma sponsors with a full-service but boutique-feel operating model. Comparable to Southern CDC in target customer segment and full-service clinical operations offering.
- Cato Clinical Services (Cato Research): Boutique CRO providing full-service clinical trial management, regulatory affairs, and drug development services to small and mid-sized pharma/biotech. Comparable to Southern CDC in boutique positioning, early-to-mid phase focus, and target biotech sponsor base.
- Veristat: Boutique CRO specializing in clinical trial design, biostatistics, and regulatory submissions for small/mid biotech. Comparable to Southern CDC in early-phase focus, senior consultant-driven delivery, and emphasis on sponsor collaboration.
- Novotech: Asia-Pacific-headquartered (Australian) CRO with strong early-phase clinical development focus. Directly comparable to Southern CDC on geography, early-stage specialization, and target biotech customer base, though at much larger scale.
Market position
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Southern Clinical Development Consulting social profiles
Digital presenceSouthern Clinical Development Consulting financial estimates
Financial estimateRevenue estimate
Valuation estimate
Southern Clinical Development Consulting leadership team
Management profileNumber of profiles
Profiles8 records
Southern Clinical Development Consulting funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Southern Clinical Development Consulting M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Southern Clinical Development Consulting
What does Southern Clinical Development Consulting do?
Southern Clinical Development Consulting is a clinical development consultancy that delivers vendor oversight and management, in-house clinical trial services, and a hybrid model leveraging vetted third-party vendors for pharmaceutical and biotech sponsors. Services span the full pre-clinical through Phase 1 (First-In-Human) pathway and include local sponsor representation, protocol and investigator brochure development, risk assessments, recruitment strategies, site startup and feasibility, site management, safety reporting, budgets and contracts, regulatory and CMC advisory, and ongoing quality control and auditing. Engagements are delivered under bespoke consultancy agreements or a master consultancy agreement that enables sponsor access to all services within two weeks.
Is Southern Clinical Development Consulting a public or private company?
Southern Clinical Development Consulting is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Southern Clinical Development Consulting founded?
Southern Clinical Development Consulting was founded in 2023. It employs 11 to 50 people.
Where is Southern Clinical Development Consulting based?
Southern Clinical Development Consulting is headquartered in Melbourne, Australia, in the Oceania region.
How does Southern Clinical Development Consulting make money?
One revenue line is on record: clinical Development Consultancy Services.
Who are Southern Clinical Development Consulting's main competitors?
Broad incumbents on record are Syneos Health, Worldwide Clinical Trials, IQVIA and Parexel. Direct peers are Biorasi, Cromos Pharma, Medpace, Cato Clinical Services (Cato Research), Veristat and Novotech.
Does Southern Clinical Development Consulting have an API?
No public API is recorded for Southern Clinical Development Consulting.
What industry is Southern Clinical Development Consulting in?
Southern Clinical Development Consulting's product category is Clinical Development Consulting Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAIALAE, Clinical Development (Phase I–III Trial Design & Execution). Its NAICS code is 54161 and its SIC code is 8742.